Primary Site >> Liver Cancer
Gene >> FN1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. PMID: 9303362 |
Ref: Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. PMID: 15330800 |
Ref: Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. PMID: 16820872 |
Ref: Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. PMID: 17827739 |
Ref: Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN2 centered network. PMID: 22623320 Ref: Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PMID: 23236287 |
Ref: Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. PMID: 24050542 Ref: N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometry. PMID: 24324730 |
Ref: Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. PMID: 24195504 Ref: Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism. PMID: 24833879 Ref: Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers. PMID: 25526364 |
Ref: Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis. PMID: 25609232 Ref: Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice. PMID: 26589287 |
Ref: Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets. PMID: 26711644 |
Ref: Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan) platform. PMID: 27663888 Ref: Analysis of differentially co-expressed genes based on microarray data of hepatocellular carcinoma. PMID: 28043148 Ref: HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis. PMID: 28580773 Ref: MiR-155 up-regulated by TGF-beta promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro. PMID: 28670383 Ref: Serum fibronectin distinguishes the early stages of hepatocellular carcinoma. PMID: 28842594 |
Ref: Chitin synthesis inhibitors promote liver cancer cell metastasis via interfering with hypoxia-inducible factor 1alpha. PMID: 29753285 Ref: Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. PMID: 29858962 Ref: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers. PMID: 29861854 Ref: Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer. PMID: 30250066 |